These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25218219)

  • 1. The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
    Alhusainy W; Williams GM; Jeffrey AM; Iatropoulos MJ; Taylor S; Adams TB; Rietjens IM
    Food Chem Toxicol; 2014 Dec; 74():28-34. PubMed ID: 25218219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
    Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
    Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
    Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
    Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyleugenol hepatocellular cancer initiating effects in rat liver.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD
    Food Chem Toxicol; 2013 Mar; 53():187-96. PubMed ID: 23220513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix-derived combination effect and risk assessment for estragole from basil-containing plant food supplements (PFS).
    van den Berg SJ; Klaus V; Alhusainy W; Rietjens IM
    Food Chem Toxicol; 2013 Dec; 62():32-40. PubMed ID: 23959103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples.
    Herrmann K; Schumacher F; Engst W; Appel KE; Klein K; Zanger UM; Glatt H
    Carcinogenesis; 2013 May; 34(5):1025-30. PubMed ID: 23334163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels.
    Tremmel R; Herrmann K; Engst W; Meinl W; Klein K; Glatt H; Zanger UM
    Arch Toxicol; 2017 Oct; 91(10):3329-3339. PubMed ID: 28326452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Methyleugenol-deoxyadenosine Adduct as a Potential Biomarker of Methyleugenol Exposure in Rats.
    Feng Y; Wang S; Wang H; Peng Y; Zheng J
    J Agric Food Chem; 2018 Feb; 66(5):1258-1263. PubMed ID: 29328669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity and genotoxicity of methyleugenol and related congeners-- a mechanism of activation for methyleugenol.
    Burkey JL; Sauer JM; McQueen CA; Sipes IG
    Mutat Res; 2000 Sep; 453(1):25-33. PubMed ID: 11006409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
    Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J
    Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2.
    Herrmann K; Engst W; Meinl W; Florian S; Cartus AT; Schrenk D; Appel KE; Nolden T; Himmelbauer H; Glatt H
    Carcinogenesis; 2014 Apr; 35(4):935-41. PubMed ID: 24318996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat.
    Al-Subeihi AA; Spenkelink B; Rachmawati N; Boersma MG; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Toxicol In Vitro; 2011 Feb; 25(1):267-85. PubMed ID: 20828604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat.
    Al-Subeihi AA; Spenkelink B; Punt A; Boersma MG; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2012 May; 260(3):271-84. PubMed ID: 22445790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods.
    Herrmann K; Engst W; Appel KE; Monien BH; Glatt H
    Mutagenesis; 2012 Jul; 27(4):453-62. PubMed ID: 22337896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD; Perrone CE
    Eur J Cancer Prev; 2007 Dec; 16(6):528-34. PubMed ID: 18090125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells.
    Jeurissen SM; Punt A; Delatour T; Rietjens IM
    Food Chem Toxicol; 2008 Jun; 46(6):2296-302. PubMed ID: 18433972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
    Bristol DW
    Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.